Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
Introduction to Epidemiology01:26

Introduction to Epidemiology

Epidemiology, known as the cornerstone of public health, involves studying the distribution and determinants of health-related events in defined populations and applying these insights to control health issues. This is essential for understanding how diseases spread, identifying populations at greater risk, and implementing measures to control or prevent outbreaks. Epidemiology addresses not only infectious diseases but also non-communicable conditions like cancer and cardiovascular disease,...
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolomic signatures of dietary carbohydrates and differential association with type 2 diabetes.

Nature health·2026
Same author

Low-fat dietary pattern and dementia mortality: a secondary analysis of the Women's Health Initiative dietary modification randomized clinical trial with long-term follow-up.

Menopause (New York, N.Y.)·2026
Same author

The semi-competing risk problem revisited.

Lifetime data analysis·2026
Same author

Estimating attributable risk functions for censored time-to-event in disease prevention research.

Lifetime data analysis·2026
Same author

Sex Differences in Measures of Energy Expenditure and Body Composition in Young, Middle-Aged, and Older Adults.

Current developments in nutrition·2026
Same author

Biomarkers for dietary fatty acid densities among postmenopausal United States females derived using a habitual-diet human feeding study.

The American journal of clinical nutrition·2026

Related Experiment Video

Updated: Jun 30, 2026

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
08:36

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

Published on: April 19, 2024

Data analysis methods and the reliability of analytic epidemiologic research.

Ross L Prentice1

  • 1Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA. rprentic@fhcrc.org

Epidemiology (Cambridge, Mass.)
|September 25, 2008
PubMed
Summary

Comparing randomized controlled trials and cohort studies on postmenopausal estrogen-plus-progestin therapy reveals consistent findings. Both study types show increased coronary heart disease and breast cancer risks, with timing influencing outcomes.

More Related Videos

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Related Experiment Videos

Last Updated: Jun 30, 2026

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
08:36

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

Published on: April 19, 2024

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Area of Science:

  • Epidemiology
  • Clinical Trials
  • Women's Health

Background:

  • Review compares randomized controlled trial (RCT) and cohort study findings on postmenopausal hormone therapy (HT).
  • Focuses on estrogen-plus-progestin therapy (EPT) effects on coronary heart disease (CHD) and breast cancer (BC) risk.
  • Examines how timing of HT initiation relative to menopause onset influences risk profiles.

Discussion:

  • Both RCTs and cohort studies indicate an early rise in CHD risk and a later increase in BC risk with EPT.
  • Initiating HT within a few years post-menopause may offer more favorable CHD outcomes but less favorable BC outcomes.
  • Highlights the importance of considering the menopausal transition phase when evaluating HT risks and benefits.

Key Insights:

  • Consistent agreement between RCTs and cohort studies on EPT's dual risk profile for CHD and BC.
  • Evidence suggests a temporal window for HT initiation may modify specific health risks.
  • Modern data analysis techniques can improve the interpretation and reliability of observational and interventional studies.

Outlook:

  • Further research needed to refine understanding of HT timing and personalized risk assessment.
  • Potential for advanced statistical methods to reconcile findings across different study designs.
  • Implications for clinical guidelines on prescribing EPT for menopausal symptom management.